These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38065340)

  • 1. Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer.
    Sun L; Liu R; Wu ZJ; Liu ZY; Wan AH; Yan S; Liu C; Liang H; Xiao M; You N; Lou Y; Deng Y; Bu X; Chen D; Huang J; Zhang X; Kuang DM; Wan G
    Gastroenterology; 2024 Mar; 166(3):466-482. PubMed ID: 38065340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
    Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer.
    Ding K; Mou P; Wang Z; Liu S; Liu J; Lu H; Yu G
    Front Immunol; 2023; 14():1298524. PubMed ID: 38187388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies.
    Han YJ; Shao CY; Yao Y; Zhang Z; Fang MZ; Gong T; Zhang YJ; Li M
    Postgrad Med J; 2024 May; 100(1184):373-381. PubMed ID: 38211949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNMTs increases neoantigen-reactive T-cell toxicity against microsatellite-stable colorectal cancer in combination with radiotherapy.
    Huang KC; Ke TW; Lai CY; Hong WZ; Chang HY; Lee CY; Wu CH; Chiang SF; Liang JA; Chen JY; Yang PC; Chen WT; Chuang EY; Chao KSC
    Biomed Pharmacother; 2024 Aug; 177():116958. PubMed ID: 38917760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer.
    Wu C; Shao Y; Gu W
    Clin Transl Oncol; 2023 Jul; 25(7):1916-1928. PubMed ID: 36717514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review.
    Wu H; Deng M; Xue D; Guo R; Zhang C; Gao J; Li H
    Int J Colorectal Dis; 2024 May; 39(1):83. PubMed ID: 38809459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.
    Wang X; Fang Y; Liang W; Wong CC; Qin H; Gao Y; Liang M; Song L; Zhang Y; Fan M; Liu C; Lau HC; Xu L; Li X; Song W; Wang J; Wang N; Yang T; Mo M; Zhang X; Fang J; Liao B; Sung JJY; Yu J
    Cancer Cell; 2024 Oct; 42(10):1729-1746.e8. PubMed ID: 39303724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.
    Wu J; Lv Y; Wang N; Zhao Y; Zhang P; Liu Y; Chen A; Li J; Li X; Guo Y; Wu T; Liu A
    Eur Radiol; 2019 Jul; 29(7):3782-3790. PubMed ID: 30903331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Tim3
    Klapholz M; Drage MG; Srivastava A; Anderson AC
    J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability.
    Roh SA; Kwon YH; Lee JL; Kim SK; Kim JC
    Anticancer Res; 2021 Nov; 41(11):5431-5444. PubMed ID: 34732412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer.
    Li S; Na R; Li X; Zhang Y; Zheng T
    Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188758. PubMed ID: 35809762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
    Akbari V; Kallhor M; Mollashahi B; Movafagh A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
    Kather JN; Halama N; Jaeger D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
    Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC.
    Chen L; Jiang X; Li Y; Zhang Q; Li Q; Zhang X; Zhang M; Yu Q; Gao D
    Clin Immunol; 2022 Apr; 237():108962. PubMed ID: 35227870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.